Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
about
Investigational insulin secretagogues for type 2 diabetes.Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges.Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist.SAR Studies of Indole-5-propanoic Acid Derivatives To Develop Novel GPR40 Agonists.Structural basis for the agonist action at free fatty acid receptor 1 (FFA1R or GPR40).
P2860
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
@ast
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
@en
type
label
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
@ast
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
@en
prefLabel
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
@ast
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
@en
P2093
P2860
P356
P1476
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
@en
P2093
Koji Matsumoto
Masahiro Inoue
Masakazu Hirouchi
Masao Yoshida
Narihiro Toda
Nobuaki Watanabe
Rieko Takano
Ryutaro Nakashima
Shuichiro Ito
Takeshi Honda
P2860
P304
P356
10.1021/ML500391N
P577
2015-01-13T00:00:00Z